The historical rank and industry rank for Sun Pharma Advanced Research Co's Operating Margin % or its related term are showing as below:
BOM:532872'
s Operating Margin % Range Over the Past 10 Years
Min: -544.71 Med: -118.26 Max: 84.54
Current: 84.54
BOM:532872's Operating Margin % is ranked better than 99.9% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs BOM:532872: 84.54
Sun Pharma Advanced Research Co (BOM:532872) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Sun Pharma Advanced Research Co Operating Margin % Related Terms
Sun Pharma Advanced Research Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharma Advanced Research Co Operating Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sun Pharma Advanced Research Co Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Sun Pharma Advanced Research Co's Operating Margin % falls into.
Sun Pharma Advanced Research Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharma Advanced Research Co (BOM:532872) has a Operating Margin % of 95.55% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Sun Pharma Advanced Research Co and its competitors. According to the industry distribution chart, Sun Pharma Advanced Research Co ranks #1 out of 955 companies in the Drug Manufacturers industry, placing it in the top 0.099999999999994%.
Is Sun Pharma Advanced Research Co's Operating Margin % too high?
Sun Pharma Advanced Research Co's current Operating Margin % is 95.55%. The Drug Manufacturers industry median Operating Margin % is 7.45. Sun Pharma Advanced Research Co's value of 95.55% is 1182.6% above this industry median. Based on the distribution chart, Sun Pharma Advanced Research Co ranks #1 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sun Pharma Advanced Research Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sun Pharma Advanced Research Co's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sun Pharma Advanced Research Co ranks #1 out of 955 companies for Operating Margin %. This places Sun Pharma Advanced Research Co in the top 0% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.45. Sun Pharma Advanced Research Co's value of 95.55% is 1182.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sun Pharma Advanced Research Co's current Operating Margin % of 95.55% is 1182.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Sun Pharma Advanced Research Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sun Pharma Advanced Research Co's current Operating Margin % is 95.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharma Advanced Research Co stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co (BOM:532872) is currently considered Possible Value Trap. The stock's GF Value™ is ₹4,474.78, compared to a current price of ₹224.60 — trading 95% below its estimated fair value. The current Operating Margin % is 95.55% and 1182.6% above the Drug Manufacturers industry median of 7.45. Sun Pharma Advanced Research Co's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Sun Pharma Advanced Research Co (BOM:532872), the current Operating Margin % is 95.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sun Pharma Advanced Research Co (BOM:532872) Overvalued in 2026?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be undervalued.
The current stock price of ₹224.60 is trading 95% below its estimated GF Value™ of ₹4,474.78.
GuruFocus considers Sun Pharma Advanced Research Co to be Possible Value Trap.
Key valuation signals for BOM:532872:
Operating Margin %: 95.55%
GF Value™: ₹4,474.78 vs. price of ₹224.60 (95% below fair value)
Industry Position: 1182.6% above the Drug Manufacturers median (#1 of 955)
No single metric tells the full story. See the BOM:532872 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sun Pharma Advanced Research Co Business Description
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
52GF Score
Get the complete analysis for BOM:532872
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532872 has been successfully added to your 
